IFP Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.51K | Buy |
658
+521
| +380% | +$4.36K | ﹤0.01% | 3725 |
|
|
2026
Q1 | $1.14K | Buy |
137
+87
| +174% | +$901 | ﹤0.01% | 4168 |
|
|
2025
Q4 | $618 | Buy |
50
+2
| +4% | +$21 | ﹤0.01% | 4225 |
|
|
2025
Q3 | $423 | Buy |
+48
| New | +$373 | ﹤0.01% | 4226 |
|
|
2023
Q1 | – | Sell |
-33
| Closed | -$9K | – | 3655 |
|
|
2022
Q4 | $9K | Sell |
33
-175
| -84% | -$2.71K | ﹤0.01% | 3440 |
|
|
2022
Q3 | $19K | Sell |
208
-64
| -24% | -$1.78K | ﹤0.01% | 3120 |
|
|
2022
Q2 | $22K | Hold |
272
| – | – | ﹤0.01% | 2748 |
|
|
2022
Q1 | $22K | Buy |
272
+257
| +1,713% | +$11.3K | ﹤0.01% | 2748 |
|
|
2021
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 2984 |
|
|
2021
Q3 | $1K | Sell |
15
-271
| -95% | -$16.4K | ﹤0.01% | 3011 |
|
|
2021
Q2 | $19K | Buy |
286
+137
| +92% | +$8.8K | ﹤0.01% | 1951 |
|
|
2021
Q1 | $13K | Sell |
149
-232
| -61% | -$23.8K | ﹤0.01% | 2020 |
|
|
2020
Q4 | $34K | Buy |
381
+85
| +29% | +$7.8K | ﹤0.01% | 1587 |
|
|
2020
Q3 | $31K | Buy |
296
+254
| +605% | +$27.4K | ﹤0.01% | 1458 |
|
|
2020
Q2 | $3K | Hold |
42
| – | – | ﹤0.01% | 2252 |
|
|
2020
Q1 | $3K | Sell |
42
-10
| -19% | -$576 | ﹤0.01% | 2238 |
|
|
2019
Q4 | $3K | Hold |
52
| – | – | ﹤0.01% | 2364 |
|
|
2019
Q3 | $3K | Buy |
+52
| New | +$2.42K | ﹤0.01% | 2526 |
|
|
2019
Q1 | – | Sell |
-205
| Closed | -$12K | – | 2622 |
|
|
2018
Q4 | $12K | Sell |
205
-2
| -1% | -$129 | ﹤0.01% | 2400 |
|
|
2018
Q3 | $14K | Buy |
207
+69
| +50% | +$4.03K | ﹤0.01% | 2650 |
|
|
2018
Q2 | $7K | Buy |
138
+107
| +345% | +$5.58K | ﹤0.01% | 3084 |
|
|
2018
Q1 | $1K | Hold |
31
| – | – | ﹤0.01% | 3619 |
|
|
2017
Q4 | $1K | Hold |
31
| – | – | ﹤0.01% | 3670 |
|
|
2017
Q3 | $1K | Hold |
31
| – | – | ﹤0.01% | 3883 |
|
|
2017
Q2 | $1K | Hold |
31
| – | – | ﹤0.01% | 3864 |
|
|
2017
Q1 | $1K | Hold |
31
| – | – | ﹤0.01% | 3783 |
|
|
2016
Q4 | $1K | Hold |
31
| – | – | ﹤0.01% | 3764 |
|
|
2016
Q3 | $1K | Sell |
31
-309
| -91% | -$8.98K | ﹤0.01% | 3704 |
|
|
2016
Q2 | $10K | Buy |
+340
| New | +$13.3K | ﹤0.01% | 2733 |
|
|
2016
Q1 | – | Sell |
-519
| Closed | -$21K | – | 2624 |
|
|
2015
Q4 | $21K | Buy |
+519
| New | +$18.1K | ﹤0.01% | 2131 |
|
Other funds holding EBS
OHA
IFP Advisors's EBS Position: Q2 2026 in Review
IFP Advisors increased its Emergent Biosolutions (EBS) stake by 380% in Q2 2026, buying an estimated $4.36K and bringing the position to 658 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.
IFP Advisors first reported a position in EBS in Q4 2015 and has held it in 30 quarters since. The position peaked at $34K in Q4 2020. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- IFP Advisors held 658 shares of Emergent Biosolutions worth $5.51K as of Q2 2026.
- IFP Advisors bought 521 Emergent Biosolutions shares in Q2 2026, an estimated $4.36K.
- Emergent Biosolutions made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3725 holding.
- IFP Advisors first reported a position in Emergent Biosolutions in Q4 2015 and has held it in 30 quarters since.
- IFP Advisors's Emergent Biosolutions position peaked at $34K in Q4 2020.
- 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.